231 related articles for article (PubMed ID: 21183789)
21. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
[TBL] [Abstract][Full Text] [Related]
22. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.
Mousavi SF; Soroosh P; Takahashi T; Yoshikai Y; Shen H; Lefrançois L; Borst J; Sugamura K; Ishii N
J Immunol; 2008 Nov; 181(9):5990-6001. PubMed ID: 18941188
[TBL] [Abstract][Full Text] [Related]
23. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.
Wortzman ME; Clouthier DL; McPherson AJ; Lin GH; Watts TH
Immunol Rev; 2013 Sep; 255(1):125-48. PubMed ID: 23947352
[TBL] [Abstract][Full Text] [Related]
24. An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.
Sanchez PJ; Kedl RM
Vaccine; 2012 Feb; 30(6):1154-61. PubMed ID: 22178730
[TBL] [Abstract][Full Text] [Related]
25. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.
Kurche JS; Burchill MA; Sanchez PJ; Haluszczak C; Kedl RM
J Immunol; 2010 Aug; 185(4):2106-15. PubMed ID: 20639485
[TBL] [Abstract][Full Text] [Related]
26. Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.
Fuse S; Tsai CY; Rommereim LM; Zhang W; Usherwood EJ
Cell Immunol; 2011; 266(2):130-4. PubMed ID: 21040905
[TBL] [Abstract][Full Text] [Related]
27. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
Braxton CL; Puckett SH; Mizel SB; Lyles DS
J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
[TBL] [Abstract][Full Text] [Related]
28. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
29. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
Lee SJ; Rossi RJ; Lee SK; Croft M; Kwon BS; Mittler RS; Vella AT
J Immunol; 2007 Aug; 179(4):2203-14. PubMed ID: 17675480
[TBL] [Abstract][Full Text] [Related]
30. Costimulation signals for memory CD8+ T cells during viral infections.
Duttagupta PA; Boesteanu AC; Katsikis PD
Crit Rev Immunol; 2009; 29(6):469-86. PubMed ID: 20121696
[TBL] [Abstract][Full Text] [Related]
31. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.
Mathew A; O'Bryan J; Marshall W; Kotwal GJ; Terajima M; Green S; Rothman AL; Ennis FA
PLoS One; 2008 Oct; 3(10):e3323. PubMed ID: 18830408
[TBL] [Abstract][Full Text] [Related]
32. OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites.
Othman AS; Franke-Fayard BM; Imai T; van der Gracht ETI; Redeker A; Salman AM; Marin-Mogollon C; Ramesar J; Chevalley-Maurel S; Janse CJ; Arens R; Khan SM
Front Cell Infect Microbiol; 2018; 8():247. PubMed ID: 30073152
[TBL] [Abstract][Full Text] [Related]
33. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
34. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
35. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
[TBL] [Abstract][Full Text] [Related]
36. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.
Green S; Ennis FA; Mathew A
Vaccine; 2011 Feb; 29(8):1666-76. PubMed ID: 21195803
[TBL] [Abstract][Full Text] [Related]
37. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
38. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
39. CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
Bathke B; Pätzold J; Kassub R; Giessel R; Lämmermann K; Hinterberger M; Brinkmann K; Chaplin P; Suter M; Hochrein H; Lauterbach H
Immunology; 2018 Jun; 154(2):285-297. PubMed ID: 29281850
[TBL] [Abstract][Full Text] [Related]
40. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
